Federal contract award
75N91021F00013
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N91019D00024 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $92.1M |
| Current contract value | $92.1M |
| Potential contract value / ceiling | $92.1M |
| Start date | Aug 31, 2021 |
| Current end date | Feb 28, 2028 |
| Potential end date | Feb 28, 2028 |
| Latest award activity | Aug 28, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 28, 2026 | P00012 | $11.2M | CHILDHOOD CANCER RESEARCH AND CCDSF |
| Dec 16, 2025 | P00011 | $16.1M | CHILDHOOD CANCER RESEARCH AND CCDSF |
| Sep 10, 2025 | P00010 | $2.3M | CHILDHOOD CANCER RESEARCH AND CCDSF |
| Jul 17, 2025 | P00009 | $0 | CHILDHOOD CANCER RESEARCH AND CCDSF |
| Dec 20, 2024 | P00008 | $15.6M | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 03 IN THE AMOUNT OF $15,630,886.00. ARTICLES B.2., B.3., B.4., F.1., AND G.3. ARE REVISED ACCORDINGLY. |
| Sep 26, 2024 | P00007 | $1.5M | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIODS OF PERFORMANCE FOR OPTION 01 AND 02 AND INCREASE THE COST PLUS FIXED FEE CEILING OF OPTION 02 FROM $15,304,252 BY $1,500,000 TO $16,804,252. |
| Dec 19, 2023 | P00006 | $15.3M | THIS IS A BILATERAL MODIFICATION TO EXERCISE OPTION 2 IN THE AMOUNT OF $15,304,242 |
| Jul 7, 2023 | P00005 | $0 | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| Jan 12, 2023 | P00004 | $0 | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| Jul 28, 2022 | P00003 | $15.2M | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| Mar 2, 2022 | P00002 | $0 | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| Dec 16, 2021 | P00001 | $-1 | ENABLING NCI CLINICAL & RESEARCH DATA SHARING |
| Aug 30, 2021 | 0 | $14.9M | ENABLING NCI CLINICAL & RESEARCH DATA SHARING |
Estimated positioning window
Feb 28, 2027 – Aug 28, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2028-02-28 (491 days from calculation)
- +25 points
- 240 historical awards in this buyer and category group
- +15 points
- 13 recorded award transactions
- +10 points
- Latest award action: 2026-08-28
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.